Journal of Clinical Medicine (May 2024)

Myopia Is an Ischemic Eye Condition: A Review from the Perspective of Choroidal Blood Flow

  • Jiaul Baksh,
  • Deokho Lee,
  • Kiwako Mori,
  • Yan Zhang,
  • Hidemasa Torii,
  • Heonuk Jeong,
  • Jing Hou,
  • Kazuno Negishi,
  • Kazuo Tsubota,
  • Toshihide Kurihara

DOI
https://doi.org/10.3390/jcm13102777
Journal volume & issue
Vol. 13, no. 10
p. 2777

Abstract

Read online

Myopia is a common refractive error that affects a large proportion of the population. Recent studies have revealed that alterations in choroidal thickness (ChT) and choroidal blood flow (ChBF) play important roles in the progression of myopia. Reduced ChBF could affect scleral cellular matrix remodeling, which leads to axial elongation and further myopia progression. As ChT and ChBF could be used as potential biomarkers for the progression of myopia, several recent myopia treatments have targeted alterations in ChT and ChBF. Our review provides a comprehensive overview of the recent literature review on the relationship between ChBF and myopia. We also highlight the importance of ChT and ChBF in the progression of myopia and the potential of ChT as an important biomarker for myopia progression. This summary has significant implications for the development of novel strategies for preventing and treating myopia.

Keywords